• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-221 可挽救帕金森病小鼠模型中多巴胺能神经元的丢失。

microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.

机构信息

Department 7 of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.

College of Mechanical and Electrical Engineering, Cangzhou Normal University, Cangzhou, Hebei, China.

出版信息

Brain Behav. 2023 Mar;13(3):e2921. doi: 10.1002/brb3.2921. Epub 2023 Feb 16.

DOI:10.1002/brb3.2921
PMID:36795044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10013949/
Abstract

BACKGROUND

Parkinson's disease (PD) is one of the most common systemic neurodegenerative diseases and is related to the loss of dopaminergic neurons in the substantia nigra. Several studies verified that microRNA (miRNAs) targeting the Bim/Bax/caspase-3 signaling axis is involved in the apoptosis of dopaminergic neurons in substantia nigra. In this study, we aimed to explore the role of miR-221 in PD.

METHODS

To examine the function of miR-221 in vivo, we used a well-established 6-OHDA-induced PD mouse model. Then we conducted adenovirus-mediated miR-221 overexpression in the PD mice.

RESULTS

Our results showed that miR-221 overexpression improved motor behavior of the PD mice. We demonstrated that overexpression of miR-221 reduced the loss of dopaminergic neurons in the substantia nigra striatum by promoting their antioxidative and antiapoptosis capacities. Mechanistically, miR-221 targets Bim, thus inhibiting Bim and Bax caspase-3 mediated apoptosis signaling pathways.

CONCLUSION

Our findings suggest miR-221 participates in the pathological process of PD and might be a potential drug target and provide new insight into PD treatment.

摘要

背景

帕金森病(PD)是最常见的系统性神经退行性疾病之一,与黑质中多巴胺能神经元的丧失有关。几项研究证实,针对 Bim/Bax/caspase-3 信号轴的 microRNA(miRNAs)参与了黑质中多巴胺能神经元的凋亡。在这项研究中,我们旨在探讨 miR-221 在 PD 中的作用。

方法

为了研究 miR-221 在体内的功能,我们使用了已建立的 6-OHDA 诱导的 PD 小鼠模型。然后,我们在 PD 小鼠中进行了腺病毒介导的 miR-221 过表达。

结果

我们的结果表明,miR-221 的过表达改善了 PD 小鼠的运动行为。我们证明,通过促进其抗氧化和抗凋亡能力,miR-221 的过表达减少了黑质纹状体中多巴胺能神经元的丢失。机制上,miR-221 靶向 Bim,从而抑制 Bim 和 Bax caspase-3 介导的凋亡信号通路。

结论

我们的发现表明 miR-221 参与了 PD 的病理过程,可能是一个潜在的药物靶点,并为 PD 的治疗提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/766ec9e7c036/BRB3-13-e2921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/9d6bc286519a/BRB3-13-e2921-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/3d5b721b23dc/BRB3-13-e2921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/96735f98bcc5/BRB3-13-e2921-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/618196656edb/BRB3-13-e2921-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/1e4c769e14ff/BRB3-13-e2921-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/766ec9e7c036/BRB3-13-e2921-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/9d6bc286519a/BRB3-13-e2921-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/3d5b721b23dc/BRB3-13-e2921-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/96735f98bcc5/BRB3-13-e2921-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/618196656edb/BRB3-13-e2921-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/1e4c769e14ff/BRB3-13-e2921-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c57b/10013949/766ec9e7c036/BRB3-13-e2921-g002.jpg

相似文献

1
microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.miRNA-221 可挽救帕金森病小鼠模型中多巴胺能神经元的丢失。
Brain Behav. 2023 Mar;13(3):e2921. doi: 10.1002/brb3.2921. Epub 2023 Feb 16.
2
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.在MPTP处理的帕金森病小鼠模型和碘代MPP处理的MN9D细胞中,miR-124的下调调节了钙蛋白酶/细胞周期蛋白依赖性激酶5(calpain/cdk5)信号通路蛋白的表达。
Neuroscience. 2014 Jul 11;272:167-79. doi: 10.1016/j.neuroscience.2014.04.039. Epub 2014 Apr 30.
3
The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.SNHG8/miRNA-421-3p/Sorting Nexin 8 轴在帕金森病小鼠模型中黑质多巴胺能神经元中的作用机制。
Neurochem Res. 2023 Mar;48(3):942-955. doi: 10.1007/s11064-022-03795-7. Epub 2022 Nov 18.
4
Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.下调 microRNA-329 的表达通过 FoxO3a 信号通路调控 CDKN2D 表达抑制帕金森病大鼠黑质多巴胺能神经元凋亡。
J Cell Physiol. 2018 Nov;233(11):8617-8629. doi: 10.1002/jcp.26608. Epub 2018 May 15.
5
MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease.MicroRNA-326 通过靶向 XBP1 抑制 iNOS 表达并通过 JNK 信号通路促进帕金森病小鼠模型中多巴胺能神经元自噬。
J Cell Biochem. 2019 Sep;120(9):14995-15006. doi: 10.1002/jcb.28761. Epub 2019 May 28.
6
Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.在帕金森病小鼠中,受抑制的微小RNA-96通过靶向CACNG5使丝裂原活化蛋白激酶(MAPK)信号通路失活,从而抑制诱导型一氧化氮合酶(iNOS)表达和多巴胺能神经元凋亡。
Mol Med. 2018 Nov 28;24(1):61. doi: 10.1186/s10020-018-0059-9.
7
Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease.过表达 microRNA-183 通过抑制 OSMR 促进帕金森病小鼠模型中黑质神经元的凋亡。
Int J Mol Med. 2019 Jan;43(1):209-220. doi: 10.3892/ijmm.2018.3982. Epub 2018 Nov 7.
8
HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2 miR-221-3p binding.HOTAIR 通过升高 NPTX2-miR-221-3p 结合来驱动帕金森病小鼠模型中黑质致密部中脑多巴胺能神经元的自噬。
Aging (Albany NY). 2020 May 12;12(9):7660-7678. doi: 10.18632/aging.103028.
9
MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax.MicroRNA-216a 通过靶向 Bax 抑制细胞帕金森病模型中的神经元凋亡。
Metab Brain Dis. 2020 Apr;35(4):627-635. doi: 10.1007/s11011-020-00546-x. Epub 2020 Mar 5.
10
LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.长链非编码 RNA H19 通过 HPRT1 介导的 Wnt/β-连环蛋白信号通路调节 microRNA-301b-3p 减轻帕金森病中多巴胺能神经元的丢失。
Aging (Albany NY). 2020 May 20;12(10):8820-8836. doi: 10.18632/aging.102877.

引用本文的文献

1
Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson's disease and synucleinopathies.帕金森病和突触核蛋白病中神经元功能障碍及非编码RNA对基因的调控
Front Cell Neurosci. 2024 Jan 5;17:1328269. doi: 10.3389/fncel.2023.1328269. eCollection 2023.

本文引用的文献

1
The BCL-2 family members NOXA and BIM mediate fluorizoline-induced apoptosis in multiple myeloma cells.BCL-2 家族成员 NOXA 和 BIM 介导氟他胺诱导多发性骨髓瘤细胞凋亡。
Biochem Pharmacol. 2020 Oct;180:114198. doi: 10.1016/j.bcp.2020.114198. Epub 2020 Aug 13.
2
Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.蜂胶作为帕金森病潜在的疾病修饰策略:6-OHDA 大鼠模型中的心脏保护和神经保护作用。
Nutrients. 2020 May 26;12(6):1551. doi: 10.3390/nu12061551.
3
LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
长链非编码 RNA H19 通过 HPRT1 介导的 Wnt/β-连环蛋白信号通路调节 microRNA-301b-3p 减轻帕金森病中多巴胺能神经元的丢失。
Aging (Albany NY). 2020 May 20;12(10):8820-8836. doi: 10.18632/aging.102877.
4
Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.上调 microRNA-375 可通过抑制 SP1 减轻帕金森病中多巴胺能神经元的损伤,减少氧化应激和炎症。
Aging (Albany NY). 2020 Jan 11;12(1):672-689. doi: 10.18632/aging.102649.
5
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy.帕金森病治疗的药物治疗现状:从单靶点治疗向多靶点治疗的转变。
Drug Discov Today. 2019 Sep;24(9):1769-1783. doi: 10.1016/j.drudis.2019.05.003. Epub 2019 May 16.
6
Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker.特发性帕金森病患者血浆微小RNA-105-5p水平升高:一种潜在的疾病生物标志物。
Front Neurosci. 2019 Mar 18;13:218. doi: 10.3389/fnins.2019.00218. eCollection 2019.
7
Partial depletion of dopaminergic neurons in the substantia nigra impairs olfaction and alters neural activity in the olfactory bulb.黑质多巴胺能神经元的部分耗竭会损害嗅觉,并改变嗅球中的神经活动。
Sci Rep. 2019 Jan 22;9(1):254. doi: 10.1038/s41598-018-36538-2.
8
Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice.葛根素通过 Bcl-2/Bax/cleaved caspase-3 和 Sirt3/SOD2 凋亡途径减轻蛛网膜下腔出血小鼠的神经功能缺损。
Biomed Pharmacother. 2019 Jan;109:726-733. doi: 10.1016/j.biopha.2018.10.161. Epub 2018 Nov 5.
9
Parkinson's disease: a short story of 200 years.帕金森病:200 年的简史。
Histol Histopathol. 2019 Jun;34(6):573-591. doi: 10.14670/HH-18-073. Epub 2018 Dec 12.
10
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.